SCHEMBL8553088

SCHEMBL8553088

OCc1nc(CCCCCc2ccccc2)cs1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.54
HDAC6 Q9UBN7 4/20 0.54
NOS1 P29475 1/20 0.47
PDE5A O76074 1/20 0.43
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
PDE1C Q14123 1/20 0.43
DHFR P00374 2/20 0.43
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CES1 P23141 2/20 0.40
LTB4R Q15722 1/20 0.40
SIGMAR1 Q99720 2/20 0.40
DAGLA Q9Y4D2 1/20 0.38
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551370 0.84 HDAC1 (0.51) HDAC1HDAC6NOS1PDE5APDE1A
SCHEMBL8641341 0.83 HDAC1 (0.47) HDAC1HDAC6NOS1PDE5APDE1A
SCHEMBL15522839 0.76 HDAC1 (0.55) HDAC1HDAC6PDE5APDE1APDE1B
SCHEMBL396385 0.76 MAPT (0.56) HDAC1HDAC6NOS1CYP2D6MAPT
SCHEMBL1809552 0.76 HDAC1 (0.51) HDAC1HDAC6NOS1PDE5APDE1A
SCHEMBL27426865 0.75 SLC6A3 (0.43) HDAC1HDAC6
SCHEMBL10918996 0.73 HDAC1 (0.58) HDAC1HDAC6NOS1MAPT
SCHEMBL201216 0.72 NOS1 (0.60) HDAC1HDAC6NOS1DHFR
SCHEMBL8214495 0.72 NOS1 (0.65) HDAC1HDAC6NOS1DHFR
SCHEMBL15522909 0.72 HDAC1 (0.67) HDAC1HDAC6PDE5APDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865429-A1 AZETIDINONE COMPOUNDS FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-09-23 EP disclosed
WO-1997021676-A1 AZETIDINONE COMPOUNDS FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-06-19 WO disclosed